Resources

Medical devices play an essential role in the prevention, diagnosis, and treatment of maternal, neonatal, and child health (MNCH) in low- and middle-income countries. However, medical devices have unique characteristics that make them difficult to manage effectively, particularly in low-resource settings.As countries experience rising life expectancy and a shift toward noncommunicable disease burden, demand is growing rapidly for device-intensive services like life support and chronic disease management. There is also an expectation that this growing need will be met with domestic rather than donor resources as countries move up in income status. Strengthening access to medical devices is therefore a critical area for health system investment.This fact sheet offers an overview of the Market Dynamics for MNCH Medical Devices project (MD4MD), which aims to diagnose key barriers that impede access to MNCH medical devices in low- and middle-income countries and prioritize potential solutions to address these barriers.

Working across 24 countries in sub-Saharan Africa as well as Cambodia and Colombia, the PMI VectorLink Project is working with national malaria programs to plan and implement safe, cost-effective, and sustainable IRS, ITN, and other life-saving malaria vector control interventions with the overall goal of reducing the burden of malaria.PMI VectorLink works with national malaria programs to compile, analyze, and visualize relevant existing data to guide vector control decisions and strategies. National program and partner datasets are integrated for review and analysis, including entomological, epidemiological, intervention coverage, and climatological data. PMI VectorLink addresses barriers to using existing data through dashboards that make relevant data more easily accessible, digestible, timely, and action-oriented.In Nigeria, through a PATH-led integrated data analytics and visualization activity, PMI VectorLink is using data to mitigate the impact of insecticide resistance. This case study explores the opportunity and challenge of using new nets formulated to combat insecticide resistance, and how data is assisting decision-making.The PMI VectorLink project is being led by Abt Associates in partnership with Population Services International and PATH along with the support of Liverpool School of Tropical Medicine, Malaria Consortium, Innovative Vector Control Consortium, McKinsey & Company, Inc., EnCompass LLC, BAO Systems LLC, Digital Globe, and Dimagi, Inc.

Viral hepatitis affects 325 million people worldwide and claims 1.4 million lives per year, despite a vaccine and effective treatments for hepatitis B (HBV) and a cure for hepatitis C (HCV). In Vietnam, viral hepatitis is the third leading cause of death, with 8 million new infections annually from HBV and HCV combined. HepLINK, a new PATH initiative in partnership with The Hepatitis Fund (EndHep2030), demonstrates a model of decentralized and integrated viral hepatitis service delivery in support of Vietnam's goal to eliminate viral hepatitis by 2030. This fact sheet provides an overview of the project and its intended outcomes.

This lessons learned documents provides an overview of Myanmar's fortified rice project spanning six years of project implementation. The brief gives an overview of achievements and challenges under key critical factors that underpin the progress of introducing fortified rice in Myanmar: 1) Key relationships and actors; 2) Public and social-sector interventions; 3) Competitive pricing; and 4) Marketing and media. Recommendations for scale-up are provided in the brief to pave the way forward.

The DMPA-SC Resource Library has been developed to provide comprehensive information on the self-injectable contraceptive subcutaneous DMPA (DMPA-SC, brand name Sayana® Press). The site features evidence, country introduction experiences, service delivery and advocacy tools, and more for global- and country-level family planning implementers and decision-makers.It is hosted by the Injectables Access Collaborative, an initiative led by PATH in partnership with the Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, and JSI. The Access Collaborative provides data-driven technical assistance, coordination, resources, and tools to ensure that women and girls have increased access to DMPA-SC and self-injection as part of an expanded range of contraceptive methods, delivered through informed choice programming.For more information, sign up for our mailing lists or contact FPoptions@path.org.